![Ibrahim Dagher](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ibrahim Dagher
Geen lopende functies
Vermogen: 79 515 $ op 30-06-2026
Profiel
Ibrahim B. Dagher worked as Senior Medical Director at Labcorp Drug Development, Inc. from 2018 to 2019.
From 2019 to 2021, served as Chief Medical Officer-WCG MedAvante-ProPhase at Cadent Therapeutics, Inc. Held the position of Chief Medical Officer at MedAvante-ProPhase, Inc. Worked as Chief Medical Officer at Enveric Biosciences, Inc. from 2021 to 2023.
From 2024 to 2026, held the role of Chief Medical Officer & Executive Vice President at Brainstorm Cell Therapeutics, Inc. Completed undergraduate education at Université de Bordeaux and Faculté De Médecine Necker Enfants Malades Université.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 26-02-2026 | 79.515 ( 0,72% ) | 79 515 $ | 30-06-2026 |
Eerdere bekende functies van Ibrahim Dagher
| Bedrijven | Functie | Einde |
|---|---|---|
| BRAINSTORM CELL THERAPEUTICS INC. | Hoofd Techniek/Wetenschap/O&O | 26-07-2026 |
| ENVERIC BIOSCIENCES, INC. | Hoofd Techniek/Wetenschap/O&O | 01-01-2023 |
Cadent Therapeutics, Inc.
 Cadent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel small molecule therapeutics to treat schizophrenia and other cognitive disorders | Corporate Officer/Principal | 01-12-2021 |
| COVANCE INC. | Hoofd Techniek/Wetenschap/O&O | 01-01-2019 |
MedAvante-ProPhase, Inc.
 MedAvante-ProPhase, Inc. Information Technology ServicesTechnology Services Provides echnology-enabled signal detection solutions in clinical trials of treatments for nervous system disorders | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Ibrahim Dagher
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
30
Eerstegraads connecties
7
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 7 |
|---|---|
Labcorp Drug Development, Inc.
 Labcorp Drug Development, Inc. Medical/Nursing ServicesHealth Services Provides medical laboratory testing and drug development services | Health Services |
Brainstorm Cell Therapeutics, Inc.
 Brainstorm Cell Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company, which develops innovative adult stem cell therapeutic products | Health Technology |
Université de Bordeaux
 Université de Bordeaux Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cadent Therapeutics, Inc.
Cadent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel small molecule therapeutics to treat schizophrenia and other cognitive disorders | Health Technology |
MedAvante-ProPhase, Inc.
MedAvante-ProPhase, Inc. Information Technology ServicesTechnology Services Provides echnology-enabled signal detection solutions in clinical trials of treatments for nervous system disorders | Technology Services |
Faculté De Médecine Necker Enfants Malades Université
 Faculté De Médecine Necker Enfants Malades Université Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Enveric Biosciences, Inc.
 Enveric Biosciences, Inc. Pharmaceuticals: OtherHealth Technology Develops cannabinoid medicines and combination therapies | Health Technology |
